![]() | Study programme 2025-2026 | Français | |
![]() | Drug design | ||
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-027-M | Optional UE | BERGER Gilles |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 10 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-DOYM-230 | Drug design | 10 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
Analysis of a new drug from its conception, synthesis, in vitro evaluation, preclinical and clinical stages. Personal work with presentation in front of the group of students. The student chooses the molecule they wish to work on (a new molecule recently put on the market).
UE Content: description and pedagogical relevance
See AA
Prior Experience
Medicinal chemistry and organic drugs
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-DOYM-230 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-DOYM-230 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-DOYM-230 | Not applicable |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-DOYM-230 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-DOYM-230 | Not applicable |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-DOYM-230 | Authorized |
Term 1 Assessment - type
| AA | Type(s) and mode(s) of Q1 assessment |
|---|---|
| M-DOYM-230 |
|
Term 1 Assessment - comments
| AA | Term 1 Assessment - comments |
|---|---|
| M-DOYM-230 | Will be graded based on the students presentations |
Resit Assessment - Term 1 (BAB1) - type
| AA | Type(s) and mode(s) of Q1 resit assessment (BAB1) |
|---|---|
| M-DOYM-230 |
|
Resit Assessment - Term 1 (BAB1) - Comments
| AA | Resit Assessment - Term 1 (BAB1) - Comments |
|---|---|
| M-DOYM-230 | Not applicable |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-DOYM-230 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-DOYM-230 | Not applicable |